Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jessica Flores Pleasants"'
Autor:
Harmony L Tyner, Jefferey L Burgess, Lauren Grant, Manjusha Gaglani, Jennifer L Kuntz, Allison L Naleway, Natalie J Thornburg, Alberto J Caban-Martinez, Sarang K Yoon, Meghan K Herring, Shawn C Beitel, Lenee Blanton, Janko Nikolich-Zugich, Matthew S Thiese, Jessica Flores Pleasants, Ashley L Fowlkes, Karen Lutrick, Kayan Dunnigan, Young M Yoo, Spencer Rose, Holly Groom, Jennifer Meece, Meredith G Wesley, Natasha Schaefer-Solle, Paola Louzado-Feliciano, Laura J Edwards, Lauren E W Olsho, Mark G Thompson
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Data on the development of neutralizing antibodies (nAbs) against SARS-CoV-2 after SARS-CoV-2 infection and after vaccination with mRNA COVID-19 vaccines are limited. Methods From a prospective cohort of 3975 adult essential and frontline
Autor:
Jennifer L. Kuntz, Natalie J. Thornburg, Matthew S. Thiese, Lauren Grant, Jennifer K. Meece, Jefferey L. Burgess, Karen Lutrick, Shawn C. Beitel, Manjusha Gaglani, Lauren E.W. Olsho, Laura J. Edwards, Kayan Dunnigan, Lenee Blanton, Mark G. Thompson, Young M Yoo, Natasha Schaefer-Solle, Janko Nikolich-Zugich, Sarang K Yoon, Harmony L. Tyner, Jessica Flores Pleasants, Allison L. Naleway, Holly C Groom, Spencer Rose, Meghan K Herring, Ashley Fowlkes, Meredith G Wesley, Alberto J. Caban-Martinez, Paola Louzado-Feliciano
BackgroundData on the development of neutralizing antibodies against SARS-CoV-2 after SARS-CoV-2 infection and after vaccination with messenger RNA (mRNA) COVID-19 vaccines are limited.MethodsFrom a prospective cohort of 3,975 adult essential and fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a01194a611b54d340d838c7986a42a5
https://doi.org/10.1101/2021.10.20.21265171
https://doi.org/10.1101/2021.10.20.21265171